Mentice Launch the latest version of Ankyras® in the United States Following FDA Clearance, Advancing Patient-Specific Aneurysm Planning for Neuro interventions
Gothenburg, Sweden, May 13, 2025, – Mentice, a globally recognized leader in simulation solutions for image-guided interventional therapies, announces that Ankyras® 4.0, its neurovascular clinical decision-support platform for patient-specific flow diverter planning, is now FDA 510(k) cleared and available for clinical use in the United States.
Read More
